[REVISION HISTORY]

TIMP2 protein research on brain immune function

Updated 1 time since CLSTR started tracking revisions of this situation.

What changed

2026-08-17 05:25 UTC → 2026-08-24 13:30 UTC · added ~~removed~~

Researchers at the Icahn School of Medicine at Mount Sinai have identified the youth-associated protein TIMP2 as a critical factor in maintaining the healthy function of microglia, the brain’s primary immune cells. Studies involving mice demonstrated that the depletion of TIMP2 leads to signs of premature aging, including increased inflammation, cellular stress, and a diminished capacity to clear cellular waste. Conversely, experimental trials showed that the systemic administration of TIMP2 in aged mice helped shift microglia away from pro-inflammatory states and restored their ability to clear debris. Published in Nature Communications, these findings suggest that TIMP2 may serve as a potential molecular mechanism for addressing age-associated neurodegeneration, such as Alzheimer’s disease, by targeting the functional state of the brain's immune cells. Joseph M. Castellano, PhD, noted that TIMP2 may help restore microglial functions that typically decline with age. Because aging is the primary risk factor for Alzheimer’s and other neurodegenerative disorders, the research offers new insights into how biological factors influence the aging brain.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.